ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/076/SRR31096276/SRR31096276.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/074/SRR31096274/SRR31096274.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/070/SRR31096270/SRR31096270.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/081/SRR31096281/SRR31096281.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/079/SRR31096279/SRR31096279.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/068/SRR31096268/SRR31096268.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/072/SRR31096272/SRR31096272.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/069/SRR31096269/SRR31096269.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/077/SRR31096277/SRR31096277.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/075/SRR31096275/SRR31096275.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/080/SRR31096280/SRR31096280.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/078/SRR31096278/SRR31096278.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/073/SRR31096273/SRR31096273.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/082/SRR31096282/SRR31096282.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR310/071/SRR31096271/SRR31096271.fastq.gzprimaryOK200GenomicsTranslational Sciences Oncology Computational Biology, Bayer AGhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1176846Homo sapiensxref:PubMed:39769434LNCaP prostate cancer cells were stimulated with the synthetic androgen R1881. RNA-sequencing was performed to identify changes induced by darolutamide treatment on the transcriptome level. Overall design: Prostate androgen-sensitive cell lines LNCaP were grown for two days in starvation medium prior to treatment with synthetic androgen R1881 at a concentration of 1 nM or R1881 with darolutamide at a concentration of 2 µM. The cells were harvested 22 h post-induction for RNA isolation and sequencing.ENAfalseRNA-sequencing of LNCaP prostate cancer cells with and without treatment of darolutamideRNA-sequencing of LNCaP prostate cancer cells with and without treatment of darolutamide2025-09-242025-01-07PRJNA1176846GSE280187960639769434